From October 1, 2021 to December 31, 2021, the company has repurchased 22,603 shares, representing 0.15% for KRW 731.46 million. With this, the company has completed the repurchase of 29,720 shares, representing 0.2% for KRW 1,124.9 million under the buyback announced on December 10, 2020.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
15,620 KRW | -0.06% |
|
+0.58% | -8.65% |
1st Jan change | Capi. | |
---|---|---|
-8.65% | 16Cr | |
+25.40% | 4.53TCr | |
+38.38% | 2.43TCr | |
+26.53% | 1.65TCr | |
+21.19% | 1.46TCr | |
+71.91% | 1.43TCr | |
-0.05% | 678.76Cr | |
-11.63% | 656.86Cr | |
+15.08% | 576.04Cr | |
-8.87% | 572.55Cr |
- Stock Market
- Equities
- A271980 Stock
- News Jeil Pharmaceutical Co.,Ltd
- Tranche Update on Jeil Pharmaceutical Co.,Ltd's Equity Buyback Plan announced on December 10, 2020.